The global biosimulation market size was valued at USD 3.5 billion in 2024, with North America holding a substantial market share. The market is driven by technological advancements in biosimulation software. It is expected to grow at a CAGR of 16.90% during the forecast period of 2025-2034, with the values likely to attain USD 14.1 billion by 2034. This growth is attributed to the expanding...